Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation the Effect of the Double Maintenance Dose of Clopidogrel Versus Single Dose in Patients With Coronary Artery Disease With a BMI ≥ 27 kg.m-2

NCT01509365 is registered in ClinicalTrials.gov with Les Laboratoires des Médicaments Stériles as lead sponsor.

NCT NCT01509365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01509365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation the Effect of the Double Maintenance Dose of Clopidogrel Versus Single Dose in Patients With Coronary Artery Disease With a BMI ≥ 27 kg.m-2
Lead sponsor
Les Laboratoires des Médicaments Stériles
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2011
Completion date
May 31, 2015
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, overweight